Good morning :)
Place Order
Add to Watchlist

Jenburkt Pharmaceuticals Ltd

JENBURPH Share Price

1,336.000.28% (+3.70)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹588 cr, stock is ranked 1,741

High Risk

Stock is 3.44x as volatile as Nifty

JENBURPH Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹588 cr, stock is ranked 1,741

High Risk

Stock is 3.44x as volatile as Nifty

JENBURPH Performance & Key Metrics

JENBURPH Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
18.374.061.35%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.406.690.82%

JENBURPH Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

JENBURPH Company Profile

Jenburkt Pharmaceuticals Limited is engaged in the manufacture of pharmaceutical formulations. The Company offers prescription and over-the-counter drugs.

JENBURPH Similar Stocks (Peers)

Compare with peers Compare with peers 

JENBURPH Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
8.35%
8.35%
Buy Reco %
87.88
87.88
Cipla Ltd
CIPLA
PE Ratio
23.39
23.39
1Y Return
5.01%
5.01%
Buy Reco %
74.19
74.19
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
19.82
19.82
1Y Return
9.60%
9.60%
Buy Reco %
56.67
56.67
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
58.02
58.02
1Y Return
11.78%
11.78%
Buy Reco %
72.00
72.00
Zydus Lifesciences Ltd
ZYDUSLIFE
PE Ratio
21.67
21.67
1Y Return
11.18%
11.18%
Buy Reco %
46.43
46.43
Compare with Peers

JENBURPH Forecast

JENBURPH Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

JENBURPH

JENBURPH

Income

Balance Sheet

Cash Flow

JENBURPH Income Statement

JENBURPH Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 3.07%, vs industry avg of 9.02%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.06% to 0.04%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 5.59%, vs industry avg of 15.29%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue106.27118.06126.05123.11113.60128.93141.87146.64158.41158.41
Raw Materialssubtract32.5130.5138.7533.5526.9133.7231.6730.80111.30111.30
Power & Fuel Costsubtract0.530.610.590.590.500.610.760.75
Employee Costsubtract25.2127.6931.2036.5132.3836.4938.8142.49
Selling & Administrative Expensessubtract26.6127.3028.1025.4623.0324.3229.0331.04
Operating & Other expensessubtract-1.274.78-0.953.036.621.596.123.77
Depreciation/Amortizationsubtract1.791.501.352.302.041.902.262.342.732.73
Interest & Other Itemssubtract0.410.410.390.530.470.430.370.270.450.45
Taxes & Other Itemssubtract6.978.056.836.275.147.588.259.2011.8711.88
EPS29.0637.2643.1232.4035.9748.5754.6558.8772.6572.62
DPS8.109.0010.208.1010.2012.0014.4015.3018.0015.30
Payout ratio0.280.240.240.250.280.250.260.260.250.21
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

JENBURPH Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

JENBURPH Stock Peers

JENBURPH Past Performance & Peer Comparison

JENBURPH Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Jenburkt Pharmaceuticals Ltd18.374.061.35%
Sun Pharmaceutical Industries Ltd37.006.030.95%
Cipla Ltd23.394.601.05%
Dr Reddy's Laboratories Ltd19.823.970.60%

JENBURPH Stock Price Comparison

Compare JENBURPH with any stock or ETF
Compare JENBURPH with any stock or ETF
JENBURPH
Loading...

JENBURPH Holdings

JENBURPH Shareholdings

JENBURPH Promoter Holdings Trend

JENBURPH Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

JENBURPH Institutional Holdings Trend

JENBURPH Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

JENBURPH Shareholding Pattern

JENBURPH Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding46.68%0.00%0.12%0.00%53.20%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

JENBURPH Shareholding History

JENBURPH Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

JENBURPH Insider Trades & Bulk Stock Deals

JENBURPH Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing JENBURPH stock

smallcases containing JENBURPH stock

Looks like this stock is not in any smallcase yet.

JENBURPH Events

JENBURPH Events

JENBURPH Dividend Trend

Increasing Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

JENBURPH has increased dividends consistently over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.35%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹13.49 every year

Dividends

Corp. Actions

Announcements

Legal Orders

JENBURPH Dividend Trend

Increasing Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

JENBURPH has increased dividends consistently over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.35%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹13.49 every year

JENBURPH Upcoming Dividends

JENBURPH Upcoming Dividends

No upcoming dividends are available

JENBURPH Past Dividends

JENBURPH Past Dividends

Cash Dividend

Ex DateEx DateJul 23, 2024

Final
Final | Div/Share: ₹15.30

Dividend/Share

₹15.30

Ex DateEx Date

Jul 23, 2024

Cash Dividend

Ex DateEx DateJul 19, 2023

Final
Final | Div/Share: ₹14.40

Dividend/Share

₹14.40

Ex DateEx Date

Jul 19, 2023

Cash Dividend

Ex DateEx DateJul 21, 2022

Final
Final | Div/Share: ₹12.00

Dividend/Share

₹12.00

Ex DateEx Date

Jul 21, 2022

Cash Dividend

Ex DateEx DateAug 30, 2021

Final
Final | Div/Share: ₹10.20

Dividend/Share

₹10.20

Ex DateEx Date

Aug 30, 2021

Cash Dividend

Ex DateEx DateMar 18, 2020

Interim
Interim | Div/Share: ₹8.10

Dividend/Share

₹8.10

Ex DateEx Date

Mar 18, 2020

JENBURPH Stock News & Opinions

JENBURPH Stock News & Opinions

Corporate
Jenburkt Pharmaceuticals to hold AGM

Jenburkt Pharmaceuticals announced that the 40th Annual General Meeting(AGM) of the company will be held on 18 August 2025.Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Earnings
Jenburkt Pharmaceuticals standalone net profit rises 8.38% in the March 2025 quarter

Net profit of Jenburkt Pharmaceuticals rose 8.38% to Rs 8.54 crore in the quarter ended March 2025 as against Rs 7.88 crore during the previous quarter ended March 2024. Sales rose 5.69% to Rs 41.05 crore in the quarter ended March 2025 as against Rs 38.84 crore during the previous quarter ended March 2024. For the full year,net profit rose 23.40% to Rs 32.06 crore in the year ended March 2025 as against Rs 25.98 crore during the previous year ended March 2024. Sales rose 6.85% to Rs 151.69 crore in the year ended March 2025 as against Rs 141.97 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales41.0538.84 6 151.69141.97 7 OPM %26.4625.36 -26.6323.33 - PBDT12.6310.98 15 46.6637.52 24 PBT11.8410.36 14 43.9335.18 25 NP8.547.88 8 32.0625.98 23 Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Board of Jenburkt Pharmaceuticals recommends final dividend

Jenburkt Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 20 May 2025, inter alia, have recommended the final dividend of Rs 18 per equity Share (i.e. 180%) , subject to the approval of the shareholders.Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Jenburkt Pharmaceuticals to discuss results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 2024 as against Rs 5.40 crore during the previous quarter ended December 2023. Sales rose 3.45% to Rs 36.89 crore in the quarter ended December 2024 as against Rs 35.66 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales36.8935.66 3 OPM %23.9420.16 - PBDT10.308.47 22 PBT9.527.84 21 NP6.515.40 21 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2024 as against Rs 7.32 crore during the previous quarter ended September 2023. Sales rose 7.65% to Rs 41.22 crore in the quarter ended September 2024 as against Rs 38.29 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales41.2238.29 8 OPM %27.7323.77 - PBDT13.1610.13 30 PBT12.529.54 31 NP9.607.32 31 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live

Jenburkt Pharmaceuticals standalone net profit rises 38.18% in the June 2024 quarter

10 months agoBusiness Standard
Earnings
Jenburkt Pharmaceuticals standalone net profit rises 38.18% in the June 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 38.18% to Rs 7.42 crore in the quarter ended June 2024 as against Rs 5.37 crore during the previous quarter ended June 2023. Sales rose 11.51% to Rs 32.54 crore in the quarter ended June 2024 as against Rs 29.18 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales32.5429.18 12 OPM %28.5523.85 - PBDT10.597.93 34 PBT10.077.43 36 NP7.425.37 38 Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Jenburkt Pharmaceuticals Ltd (JENBURPH) today?

    The share price of JENBURPH as on 18th June 2025 is ₹1336. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Jenburkt Pharmaceuticals Ltd (JENBURPH) share?

    The past returns of Jenburkt Pharmaceuticals Ltd (JENBURPH) share are
    • Past 1 week: 6.03%
    • Past 1 month: 21.12%
    • Past 3 months: 38.56%
    • Past 6 months: 1.67%
    • Past 1 year: 58.84%
    • Past 3 years: 174.30%
    • Past 5 years: 256.39%

  3. What are the peers or stocks similar to Jenburkt Pharmaceuticals Ltd (JENBURPH)?

    The peers or stocks similar to Jenburkt Pharmaceuticals Ltd (JENBURPH) include:

  4. What is the dividend yield % of Jenburkt Pharmaceuticals Ltd (JENBURPH) share?

    The current dividend yield of Jenburkt Pharmaceuticals Ltd (JENBURPH) is 1.35.

  5. What is the market cap of Jenburkt Pharmaceuticals Ltd (JENBURPH) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jenburkt Pharmaceuticals Ltd (JENBURPH) is ₹588.89 Cr as of 18th June 2025.

  6. What is the 52 week high and low of Jenburkt Pharmaceuticals Ltd (JENBURPH) share?

    The 52-week high of Jenburkt Pharmaceuticals Ltd (JENBURPH) is ₹1375 and the 52-week low is ₹815.80.

  7. What is the PE and PB ratio of Jenburkt Pharmaceuticals Ltd (JENBURPH) stock?

    The P/E (price-to-earnings) ratio of Jenburkt Pharmaceuticals Ltd (JENBURPH) is 18.37. The P/B (price-to-book) ratio is 4.06.

  8. Which sector does Jenburkt Pharmaceuticals Ltd (JENBURPH) belong to?

    Jenburkt Pharmaceuticals Ltd (JENBURPH) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Jenburkt Pharmaceuticals Ltd (JENBURPH) shares?

    You can directly buy Jenburkt Pharmaceuticals Ltd (JENBURPH) shares on Tickertape. Simply sign up, connect your demat account and place your order.